×
About 8,242 results

ALLMedicine™ Ductal Carcinoma In Situ Center

Research & Reviews  3,791 results

Axillary staging in ductal carcinoma in situ with microinvasion: A meta-analysis.
https://doi.org/10.1016/j.suronc.2021.101557
Surgical Oncology; Choi B, Jegatheeswaran L et. al.

Apr 5th, 2021 - Ductal carcinoma in situ with microinvasion (DCISM); arguably a more aggressive subtype of DCIS, currently has variable recommendations governing its staging and management in the UK. As a result, there is ongoing controversy surrounding the most ...

Measurements using mammography and ultrasonography underestimate the size of high-volum...
https://doi.org/10.1016/j.amjsurg.2021.03.043
American Journal of Surgery; Liu RQ, Que J et. al.

Apr 3rd, 2021 - Surgical decisions for ductal carcinoma in situ (DCIS) are based on lesion sizes. This study aims to determine the accuracy of pre-operative imaging in estimating the size of DCIS. This was a retrospective review of clinicopathologic data of patie...

National Variations in the Work-Up, Investigation, and Surgical Management of Ductal Ca...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8025827
Current Oncology (Toronto, Ont.); Seguin R, Peiris L

Apr 3rd, 2021 - Variation in the management of Ductal Carcinoma In Situ (DCIS) of the breast occur at both national and international levels. The aim of this study is to determine the degree of, and reasons behind, this variation in the workup and treatment of DC...

see more →

Guidelines  11 results

Trastuzumab Achieves Slight Reduction in Recurrence for Women With HER2-Positive DCIS
https://ascopost.com/news/june-2020/trastuzumab-achieves-slight-reduction-in-recurrence-for-women-with-her2-positive-dcis/

Jun 7th, 2020 - The addition of trastuzumab to radiotherapy did not reach the protocol objective of a 36% reduction in the ipsilateral breast tumor recurrence rate for women with HER2-positive ductal carcinoma in situ (DCIS) in the NRG Oncology clinical trial NSA...

Association of Magnetic Resonance Imaging and a 12-Gene Expression Assay With Breast Ductal Carcinoma In Situ Treatment
https://jamanetwork.com/journals/jamaoncology/fullarticle/2721237
Lehman,C.,et al

Jan 16th, 2019 - Question What is the association of breast magnetic resonance imaging and a 12-gene expression assay with the treatment of women with ductal carcinoma in situ of the breast who are candidates for breast conservation surgery and radiotherapy? Find...

Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology
http://www.jnccn.org/content/16/3/310.full
Gradishar, W

Feb 28th, 2018 - Ductal carcinoma in situ (DCIS) of the breast represents a heterogeneous group of neoplastic lesions in the breast ducts. The goal for management of DCIS is to prevent the development of invasive breast cancer.

Margins for Breast-Conserving Surgery With Whole Breast Irradiation in Ductal Carcinoma In Situ
http://ascopubs.org/doi/full/10.1200/JCO.2016.68.3573
Monica Morrow

Nov 19th, 2016 - The use of a 2 mm margin as the standard for an adequate margin in DCIS treated with WBRT is associated with low rates of IBTR and has the potential to decrease re-excision rates, improve cosmetic outcome, and decrease health care costs. Clinical.

Society of Surgical Oncology-American Society for Radiation Oncology-American Society o...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5047939
Annals of Surgical Oncology; Morrow M, Van Zee KJ et. al.

Aug 16th, 2016 - Controversy exists regarding the optimal negative margin width for ductal carcinoma in situ (DCIS) treated with breast-conserving surgery and whole-breast irradiation. A multidisciplinary consensus panel used a meta-analysis of margin width and ip...

see more →

Drugs  1 results see all →

Clinicaltrials.gov  4,177 results

Axillary staging in ductal carcinoma in situ with microinvasion: A meta-analysis.
https://doi.org/10.1016/j.suronc.2021.101557
Surgical Oncology; Choi B, Jegatheeswaran L et. al.

Apr 5th, 2021 - Ductal carcinoma in situ with microinvasion (DCISM); arguably a more aggressive subtype of DCIS, currently has variable recommendations governing its staging and management in the UK. As a result, there is ongoing controversy surrounding the most ...

Measurements using mammography and ultrasonography underestimate the size of high-volum...
https://doi.org/10.1016/j.amjsurg.2021.03.043
American Journal of Surgery; Liu RQ, Que J et. al.

Apr 3rd, 2021 - Surgical decisions for ductal carcinoma in situ (DCIS) are based on lesion sizes. This study aims to determine the accuracy of pre-operative imaging in estimating the size of DCIS. This was a retrospective review of clinicopathologic data of patie...

National Variations in the Work-Up, Investigation, and Surgical Management of Ductal Ca...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8025827
Current Oncology (Toronto, Ont.); Seguin R, Peiris L

Apr 3rd, 2021 - Variation in the management of Ductal Carcinoma In Situ (DCIS) of the breast occur at both national and international levels. The aim of this study is to determine the degree of, and reasons behind, this variation in the workup and treatment of DC...

see more →

News  259 results

Study Helps Gauge Long-term Risks for Women With DCIS by Treatment
https://www.medscape.com/viewarticle/938743

Oct 7th, 2020 - NEW YORK (Reuters Health) - New research helps clarify the long-term risk for invasive breast cancer in women with ductal carcinoma in situ (DCIS) who opt for breast-conserving surgery alone or with radiotherapy. The study suggests that surgery fo...

Study Helps Gauge Long-term Risks for Women With DCIS by Treatment
https://www.staging.medscape.com/viewarticle/938743

Oct 7th, 2020 - NEW YORK (Reuters Health) - New research helps clarify the long-term risk for invasive breast cancer in women with ductal carcinoma in situ (DCIS) who opt for breast-conserving surgery alone or with radiotherapy. The study suggests that surgery fo...

Threefold Higher Risk for Breast Cancer Death With DCIS
https://www.medscape.com/viewarticle/937652

Sep 17th, 2020 - For women diagnosed with ductal carcinoma in situ (DCIS), the risk of dying of breast cancer was three times higher than among women in the general population, according to findings from a large epidemiologic study. Within a cohort of nearly 145,0...

Trastuzumab Achieves Slight Reduction in Recurrence for Women With HER2-Positive DCIS
https://ascopost.com/news/june-2020/trastuzumab-achieves-slight-reduction-in-recurrence-for-women-with-her2-positive-dcis/

Jun 7th, 2020 - The addition of trastuzumab to radiotherapy did not reach the protocol objective of a 36% reduction in the ipsilateral breast tumor recurrence rate for women with HER2-positive ductal carcinoma in situ (DCIS) in the NRG Oncology clinical trial NSA...

Increased Risk for Invasive Breast Cancer After DCIS
https://www.medscape.com/viewarticle/931733

Jun 3rd, 2020 - One of the controversies of routine mammography screening of healthy women is that it detects minimal-risk breast cancer, including the vast majority of ductal carcinoma in situ (DCIS), which has led to concerns of over-diagnosis and over-treatmen...

see more →

Patient Education  3 results see all →